← All updates
Observational study

Gastroenterology · 1 h ago

Single-cell study identifies SAA-expressing hepatocytes in alcohol-related hepatitis

A single-cell analysis of liver biopsies from patients with alcohol-related hepatitis (AH), early-stage alcohol-related liver disease and healthy individuals mapped disease-associated cell populations. The study also found elevated circulating serum amyloid A (SAA) in AH, associated with reduced survival, and identified a potential SAA–FPR2 inflammatory pathway.

Researchers used single-cell RNA sequencing of liver biopsies from people with AH, early-stage alcohol-related liver disease and healthy individuals to characterize cellular populations and interactions. They validated selected markers by immunofluorescence and used biopsy-derived organoids exposed to AH-conditioned medium to assess SAA secretion. The source does not report participant numbers.

The analysis identified SAA-expressing hepatocytes, scar-associated endothelial cells and macrophages, Fibulin-3-positive mesenchymal cells, T-cell subsets and hyperactivated neutrophils expressing FPR2. Cell-communication analysis predicted an interaction between hepatocyte-derived SAA and neutrophil FPR2. Organoids secreted SAA after exposure to AH-conditioned medium. Circulating SAA was elevated in AH and associated with reduced survival.

The findings nominate the SAA–FPR2 pathway as a possible contributor to inflammation in AH, but do not establish that it causes disease or that targeting it improves outcomes. The cell-interaction result is predictive, and the organoid experiments are an experimental model; the reported survival association does not demonstrate causality. The study suggests a potential research target rather than a basis for changing clinical care.

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Sign in to rate this summary →

Source

Hepatology: Single-cell landscape of alcohol-related hepatitis reveals serum amyloid a hepatocytes as key drivers of disease pathogenesis ↗

This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.